Regarding the JAK2 mutation, 37 PV patients (90.2%) carried the V617F mutation, and 1 patient (2.4%) had an exon 12 mutation, while 49 SE patients did not have the JAK2 mutation. Here, JAK2 is linked to acquired polycythemia vera.